AKT1 and prostate cancer: In prostate cancer cells, CAMK2N1 and AR signaling form an auto-regulatory negative feedback loop, where CAMK2N1 is down regulated by AR activation in response to androgen, while CAMK2N1 inhibits AR expression and activity through the CAMKII and AKT pathway.